Admission is free.
He will present the preliminary reflections and conclusions of this joint project of the Centre for Bioethics of the Clinical Research Institute of Montr al and the Legal Network, which will interest those who are thinking of enrolling in a clinical trial, those involved in public health, and researchers. In particular, she will deal with how the legal status of drugs interferes with HIV prevention and with the care, treatment, and support that HIV-positive injection drug users need. She will present concrete, realistic measures to reduce without delay the obstacles to the effectiveness of responses to HIV posed by Canadian drug legislation. She will explain why this legal framework needs to be changed in the longer term, describing the possible solutions identified in the course of a national consultation whose conclusions the Legal Network is about to publish. The current obstacles to the effectiveness of syringe exchange programs and of methadone maintenance treatment will also be addressed.